Your browser doesn't support javascript.
loading
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Nardone, Agostina; Qiu, Xintao; Spisak, Sandor; Nagy, Zsuzsanna; Feiglin, Ariel; Feit, Avery; Cohen Feit, Gabriela; Xie, Yingtian; Font-Tello, Alba; Guarducci, Cristina; Hermida-Prado, Francisco; Syamala, Sudeepa; Lim, Klothilda; Munoz Gomez, Miguel; Pun, Matthew; Cornwell, MacIntosh; Liu, Weihan; Ors, Aysegul; Mohammed, Hisham; Cejas, Paloma; Brock, Jane B; Freedman, Matthew L; Winer, Eric P; Fu, Xiaoyong; Schiff, Rachel; Long, Henry W; Metzger Filho, Otto; Jeselsohn, Rinath.
Affiliation
  • Nardone A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Spisak S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nagy Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Feiglin A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Feit A; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
  • Cohen Feit G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Font-Tello A; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Guarducci C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hermida-Prado F; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Syamala S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Munoz Gomez M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Pun M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cornwell M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Liu W; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ors A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Mohammed H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Brock JB; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Freedman ML; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Fu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Schiff R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Metzger Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jeselsohn R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Res ; 82(20): 3673-3686, 2022 10 17.
Article in En | MEDLINE | ID: mdl-35950920
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Lobular / Carcinoma, Ductal, Breast Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Res Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Lobular / Carcinoma, Ductal, Breast Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Res Year: 2022 Type: Article